Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

NCT01096381 · clinicaltrials.gov ↗
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class

Stopped funding withdrawn due to fellow's departure from VICC

Conditions

Interventions

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators